Genesis Healthcare (GENN)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated May 31, 2024 03:10 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Genesis Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 3,906 | 4,566 |
Cost Of Goods | NA | NA | NA | 0 | 0 |
Gross Profit | NA | NA | NA | 3,906 | 4,566 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 0 | 0 | 4,398 | 4,558 |
Income After Depreciation & Amortization | 0 | 0 | 0 | -492 | 8 |
Non-Operating Income | NA | NA | NA | 521 | 182 |
Interest Expense | NA | NA | NA | 135 | 180 |
Pretax Income | NA | NA | NA | -107 | 9 |
Income Taxes | NA | NA | NA | -4 | 2 |
Minority Interest | NA | NA | NA | -44 | -7 |
Investment Gains/Losses | NA | NA | NA | 0 | 0 |
Other Income/Charges | NA | NA | NA | 0 | 0 |
Income From Cont. Operations | NA | NA | NA | -103 | 7 |
Extras & Discontinued Operations | NA | NA | NA | 0 | 0 |
Net Income (GAAP) | NA | NA | NA | -59 | 15 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 0 | 0 | -384 | 131 |
Depreciation & Amortization (Cash Flow) | NA | NA | NA | 108 | 123 |
Income After Depreciation & Amortization | 0 | 0 | 0 | -492 | 8 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | 165.31 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | 0.10 |
Diluted Net EPS (GAAP) | NA | NA | NA | -0.53 | 0.10 |
Fiscal Year end for Genesis Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |